Technique kills cancerous cells, leaves healthy cells intact
Chemists at the University of Illinois at Urbana-Champaign have produced a molecule that selectively kills cancerous cells in a desired way and leaves healthy cells virtually untouched.
While encouraging, the findings dont mean a new treatment is imminent. The basic laboratory experiments were done in microtiter dishes, where the compound was simply exposed to leukemia and lymphoma cells and healthy white blood cells from mice.
"Its hard to say where this discovery may fit into the big picture, but the pathway weve found is real; it is very provocative," said Paul J. Hergenrother, a professor of chemistry, who directed the study funded by the National Science Foundation.
The study appears in the Dec. 3 issue of the Journal of the American Chemical Society. The compound, which is referred to as 13-D in the study, already is being tested by the National Cancer Institute. The University of Illinois has applied for a patent on it.
"The next big step would be to show that this compound works in an animal model," Hergenrother said. "We are very interested in the selectivity of this compound. We now are trying to track down exactly what protein target this compound is binding to in the cancer cells. If we can isolate the protein receptor, we may find a totally new anti-cancer target."
Hergenrother and his doctoral students Vitaliy Nesterenko and Karson S. Putt manufactured a library of 88 artificial compounds based on the structures of certain natural products. Three of the compounds showed a significant ability to kill cancer cells. Those three were further screened to determine if they were killing the cancer cells through apoptosis or necrosis.
Apoptosis is desired because cells die in a programmed fashion and are simply engulfed by other cells. Necrosis is essentially an accidental breakdown that results in the spilling of cellular material that triggers an undesirable anti-inflammatory response.
Compound 13-D was found to have the strongest cancer-killing effect and the only one to induce a cysteine protease known as caspase-3 as well as blebbing (a pinching off of the cellular membrane) and cell shrinkage, all of which are hallmarks of apoptosis.
"Once we had a compound that killed by apoptosis, we did the key experiment to see if the compound induced cell death selectively, choosing cancerous cells over non-cancerous white blood cells," Hergenrother said. "Compound 13-D showed virtually no toxicity toward the actively dividing T-cells while almost completely killing the lymphoma and leukemia cells."
Such results are desirable, because many current human therapeutic approaches result in undesired side effects such as anemia and major gastrointestinal problems.
Additionally, Hergenrother said, if the biological pathways can be isolated it may be possible to manufacture compounds that not only encourage apoptosis in cancer cells but also inhibit it in healthy cells, a potential benefit to sufferers of Alzheimers and Parkinsons diseases in which many cells die off unnecessarily.
Jim Barlow | EurekAlert!
The most recent press releases about innovation >>>
Die letzten 5 Focus-News des innovations-reports im Überblick:
Astronomers from Bonn and Tautenburg in Thuringia (Germany) used the 100-m radio telescope at Effelsberg to observe several galaxy clusters. At the edges of these large accumulations of dark matter, stellar systems (galaxies), hot gas, and charged particles, they found magnetic fields that are exceptionally ordered over distances of many million light years. This makes them the most extended magnetic fields in the universe known so far.
The results will be published on March 22 in the journal „Astronomy & Astrophysics“.
Galaxy clusters are the largest gravitationally bound structures in the universe. With a typical extent of about 10 million light years, i.e. 100 times the...
Researchers at the Goethe University Frankfurt, together with partners from the University of Tübingen in Germany and Queen Mary University as well as Francis Crick Institute from London (UK) have developed a novel technology to decipher the secret ubiquitin code.
Ubiquitin is a small protein that can be linked to other cellular proteins, thereby controlling and modulating their functions. The attachment occurs in many...
Layered 2D material improves efficiency for solar cells and LEDs
In the eternal search for next generation high-efficiency solar cells and LEDs, scientists at Los Alamos National Laboratory and their partners are creating...
Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are less stable. Now researchers at the Technical University of Munich (TUM) have, for the first time ever, produced a composite material combining silicon nanosheets and a polymer that is both UV-resistant and easy to process. This brings the scientists a significant step closer to industrial applications like flexible displays and photosensors.
Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are...
Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to simulate these confined natural conditions in artificial vesicles for the first time. As reported in the academic journal Small, the results are offering better insight into the development of nanoreactors and artificial organelles.
Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to...